Skip to main content
Clinical Trials/NCT05686772
NCT05686772CompletedNot Applicable

A Better Understanding of the Association Between Problem Gambling and Psychotic Disorders in Young Adults: a New Path Towards Recovery

Laval University2 sites in 1 country520 target enrollmentStarted: November 1, 2019Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
520
Locations
2
Primary Endpoint
Problem gambling

Study Overview

Brief Summary

The aims of this propsective cohort study are to get a better understanding of the association between problem gambling and psychotic disorders among young adults with first-episode psychosis.

The main questions to be answered are:

  1. What is the incidence of problem gambling in this population?
  2. What are the predictors of problem gambling in this population?

To do so, putative predictors of problem gambling will be analyzed using Cox regression models:

  • Sociodemographics (e.g., age, gender identity, ethnicity, level of education, employment);
  • Psychiatric comorbidities (e.g., substance use disorders, cluster B personality disorders);
  • Antipsychotic use (first/second-generation, third-generation [aripiprazole, brexpiprazole, cariprazine]);
  • Prior gambling history.

Detailed Description

All Cox regression models will be adjusted for site-effect. Further multivariable models will be constructed to examine the association between antipsychotic use (as continuous exposure) and incident PBG using the directed acyclic graphs approach to adjust for confounders.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 to 35 years old;
  • Diagnosis of first-episode psychosis (i.e., DSM-5 diagnosis of schizophrenia spectrum and other psychotic disorders, as well as DSM-5 bipolar disorder with psychotic features).

Exclusion Criteria

  • Active/prior PBG at te time of admission;
  • Loss to follow-up within first three months;
  • DSM-5 diagnosis of psychotic disorder due to a medical condition;
  • Severe intellectual disability.

Arms & Interventions

First-episode psychosis patients

All patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.

Intervention: Antipsychotic use (Drug)

First-episode psychosis patients

All patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.

Intervention: Psychiatric comorbidities (Other)

First-episode psychosis patients

All patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.

Intervention: Sociodemographics/socioeconomic status (Other)

First-episode psychosis patients

All patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.

Intervention: Gambling history (Other)

First-episode psychosis patients

All patients aged 18-35 years with a diagnosis of FEP admitted at two FEP programs in the province of Quebec, Canada.

Intervention: Clinical variables (Other)

Outcomes

Primary Outcomes

Problem gambling

Time Frame: Outcome assessed at every 6-month time point, from patients admission until the first occurrence of the primary outcome, loss to follow-up, or May 1, 2023.

i) Diagnosis of gambling disorder according to DSM-5 criteria, established by the treating psychiatrist, and/or; ii) Problem gambling according to a score of 8 and more on the Problem Gambling Severity Index, as questioned by the clinical case manager and/or treating psychiatrist

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Olivier Corbeil

PharmD, MSc, Pharmacist, Principal Investigator

Laval University

Study Sites (2)

Loading locations...

Similar Trials

Prospective Multicenter Cohort Study... | Clinical Trial